相关实验视频

Updated: Mar 4, 2026

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

在心血管疾病中eRNAs的作用

Yuqing Li^1,2,3,4,5, Chao Song^2,3,4,5, Jian Cui^2,3,4,5

¹School of Pharmacy, Hengyang Medical College, University of South China, 28 Western Changsheng Road, Hengyang, Hunan, 421001, China.

Current cardiology reviews

|June 10, 2025

概括

增强型RNAs (eRNAs) 是心血管疾病 (CVD) 的关键调节者. 了解它们在基因表达和表观遗传调节中的作用,为心血管疾病提供了新的诊断和治疗策略.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
心血管医学心血管医学

背景情况:

心血管疾病 (CVD) 是一个主要的全球健康问题,由复杂的致病机制驱动.
表观遗传修饰,特别是非编码RNA,在调节心血管疾病中的基因表达方面发挥着至关重要的作用.
从增强剂转录的增强子RNA (eRNA) 正在成为心血管健康和疾病的关键调节者.

研究的目的:

审查eRNA在心血管疾病 (CVD) 中的基本特征和作用机制.
突出关键的eRNA及其在心血管病理过程中的特定作用.
讨论eRNA作为CVD生物标志物和治疗点的潜力.

主要方法:

文献综述总结了目前对心血管疾病中eRNA的研究.
分析eRNA功能,包括增强剂-促进剂循环,染色体重塑和转录控制.
讨论特定的eRNAs (例如,IRENES,CARMEN,LINC00607,HERNA1,PSMB8-AS1,WISPER) 以及它们在心血管疾病发病过程中的作用.

主要成果:

eRNA通过表观遗传机制调节基因表达,影响心脏发育,血管重塑,动脉样硬化和纤维化.
特定的eRNA与转录因子相互作用,调节心血管基因调节网络.
测序方面的进展确定了eRNAs作为潜在的生物标志物和CVD诊断和治疗的治疗点.

结论:

eRNA是心血管疾病发病的关键调节者,为复杂的生物过程提供了洞察力.
针对特定的eRNA,如对动脉样硬化治疗的CARMEN或对内皮功能障碍治疗的LEENE,显示出治疗前景.
对eRNA机制的进一步研究对于开发心血管医学中新的治疗策略至关重要.

关键词:

增强器RNA 是一种增强器RNA.艾琳娜斯. 艾琳娜斯. 艾琳娜斯.心血管疾病心血管疾病这是表观遗传学.基因表达的基因表达方式转录规则转录规则转录规则

更多相关视频

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Published on: April 5, 2024

相关概念视频

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Exercise and Cardiovascular Response

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...